Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Current Leases (2019 - 2026)

Dexcom has reported Current Leases over the past 8 years, most recently at $20.5 million for Q1 2026.

  • Quarterly Current Leases fell 9.29% to $20.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $20.5 million through Mar 2026, down 9.29% year-over-year, with the annual reading at $21.6 million for FY2025, 4.0% down from the prior year.
  • Current Leases was $20.5 million for Q1 2026 at Dexcom, down from $21.6 million in the prior quarter.
  • Over five years, Current Leases peaked at $23.6 million in Q3 2025 and troughed at $20.5 million in Q4 2022.
  • The 5-year median for Current Leases is $21.6 million (2024), against an average of $21.7 million.
  • Year-over-year, Current Leases rose 14.84% in 2022 and then dropped 9.29% in 2026.
  • A 5-year view of Current Leases shows it stood at $20.5 million in 2022, then increased by 2.93% to $21.1 million in 2023, then increased by 6.64% to $22.5 million in 2024, then decreased by 4.0% to $21.6 million in 2025, then fell by 5.09% to $20.5 million in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Current Leases are $20.5 million (Q1 2026), $21.6 million (Q4 2025), and $23.6 million (Q3 2025).